Qutenza approved for post-shingles pain
The U.S. Food and Drug Administration has approved a new skin patch called Qutenza to treat postherpetic neuralgia, the nerve pain that may follow shingles.
The U.S. Food and Drug Administration has approved a new skin patch called Qutenza to treat postherpetic neuralgia, the nerve pain that may follow shingles.
Radiation treatment for patients whose skin cancer has spread to their lymph nodes may reduce the risk of recurrence, experts say.
An analysis by the Henry J. Kaiser Family Foundation has found that monthly premiums will rise an average 11 percent, though the premium changes vary widely by which plan seniors select.
Drugmakers say the current FDA guidelines requiring both benefits and risks of drugs on ads hampers advertising on the Internet given the space constraints for ads on Web pages.
Experts say that patients have started expecting their doctors to help them make decisions about their care based on the cost of treatment.
Though women generally live longer than men worldwide, scientists say that women are not able to “reach their full human potential” because their critical medical needs are not being met.
The U.S. recession has made it more difficult than ever for people to afford their prescription medications, but according to one expert, there are several options for helping make meds more affordable.
The U.S. House of Representatives passed a landmark healthcare reform after a 14-hour day of debate, with only one Republican backing the measure along with 219 Democrats.
The ice cream–called ReCharge–incorporates some active dairy bacteria that some researchers believe can help relieve diarrhea, lost appetite, and anemia in cancer patients.